Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
43,473,000
-
Share change
-
+4,567,541
-
Total reported value
-
$179,861,198
-
Put/Call ratio
-
28%
-
Price per share
-
$4.13
-
Number of holders
-
86
-
Value change
-
+$18,861,290
-
Number of buys
-
60
-
Number of sells
-
32
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2015
As of 30 Jun 2015,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,473,000 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Consonance Capital Management LP, FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Fund Advisors, Catalyst Capital Advisors LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
86
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.